Gene · 623
Papers2,473
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,341 to 1,360 of 2,473
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Protein expression, biochemical pharmacology of signal transduction, and relation to intraocular pressure modulation by bradykinin B₂ receptors in ciliary muscle. | Mol Vis | 2013 | 23805043 | PubTator, text mining | PubMed |
| Involvement of intercellular adhesion molecule-1 up-regulation in bradykinin promotes cell motility in human prostate cancers. | Int J Mol Sci | 2013 | 23803661 | PubTator, text mining | PubMed |
| Characterization of a novel proinflammatory effect mediated by BK and the kinin B₂ receptor in human preadipocytes. | Biochem Pharmacol | 2013 | 23796753 | PubTator, text mining | PubMed |
| Comparative study of deoxynivalenol, 3-acetyldeoxynivalenol, and 15-acetyldeoxynivalenol on intestinal transport and IL-8 secretion in the human cell line Caco-2. | Toxicol In Vitro | 2013 | 23792671 | PubTator, text mining | PubMed |
| A randomized, double-blind, placebo-controlled, phase II dose-finding study of the short acting β1-blocker, landiolol hydrochloride, in patients with suspected ischemic cardiac disease. | Int J Cardiovasc Imaging | 2013 | 23784548 | PubTator, text mining | PubMed |
| Expression of vascular remodelling markers in relation to bradykinin receptors in asthma and COPD. | Thorax | 2013 | 23739138 | PubTator, text mining | PubMed |
| Kinin-B2 receptor exerted neuroprotection after diisopropylfluorophosphate-induced neuronal damage. | Neuroscience | 2013 | 23735753 | PubTator, text mining | PubMed |
| ACE inhibition enhances bradykinin relaxations through nitric oxide and B1 receptor activation in bovine coronary arteries. | Biol Chem | 2013 | 23729620 | PubTator, text mining | PubMed |
| Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic review. | BMC Med | 2013 | 23721258 | PubTator, text mining | PubMed |
| A novel in vitro model for studying quiescence and activation of primary isolated human myoblasts. | PLoS One | 2013 | 23717533 | PubTator, text mining | PubMed |
| Activation of the kinin B1 receptor attenuates melanoma tumor growth and metastasis. | PLoS One | 2013 | 23691222 | PubTator, text mining | PubMed |
| Role of plasma kallikrein in diabetes and metabolism. | Thromb Haemost | 2013 | 23676986 | PubTator, text mining | PubMed |
| Hereditary angioedema: epidemiology, management, and role of icatibant. | Biologics | 2013 | 23662043 | PubTator, text mining | PubMed |
| The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers. | J Biol Chem | 2013 | 23661707 | PubTator, text mining | PubMed |
| Ustekinumab in chronic immune-mediated diseases: a review of long term safety and patient improvement. | Patient Prefer Adherence | 2013 | 23641151 | PubTator, text mining | PubMed |
| Constant or fluctuating hyperglycemias increases cytomembrane stiffness of human umbilical vein endothelial cells in culture: roles of cytoskeletal rearrangement and nitric oxide synthesis. | BMC Cell Biol | 2013 | 23601245 | PubTator, text mining | PubMed |
| Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties. | Cancer Cell | 2013 | 23597562 | PubTator, text mining | PubMed |
| The existence of myocardial repair: mechanistic insights and enhancements. | Cardiol Rev | 2013 | 23568056 | PubTator, text mining | PubMed |
| Chronic therapy with a partial adenosine A1-receptor agonist improves left ventricular function and remodeling in dogs with advanced heart failure. | Circ Heart Fail | 2013 | 23564604 | PubTator, text mining | PubMed |
| Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma. | PLoS One | 2013 | 23555867 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/623/papers?page=68